| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 4.162 | 5.421 | 2.202 | 3.361 | 2.337 | 3.641 | 5.502 |
| Total Income - EUR | - | - | 0 | 10.123 | 10.607 | 7.289 | 8.335 | 7.327 | 8.616 | 10.450 |
| Total Expenses - EUR | - | - | 1.908 | 17.036 | 19.819 | 7.033 | 6.354 | 6.383 | 7.146 | 8.232 |
| Gross Profit/Loss - EUR | - | - | -1.908 | -6.914 | -9.212 | 257 | 1.981 | 944 | 1.470 | 2.218 |
| Net Profit/Loss - EUR | - | - | -1.908 | -6.955 | -9.263 | 204 | 1.982 | 944 | 1.235 | 1.857 |
| Employees | - | - | 1 | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mbs Alfamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 43.294 | 37.194 | 31.115 | 25.438 | 19.899 | 14.970 | 9.950 | 4.947 |
| Current Assets | - | - | 43.920 | 711 | 700 | 251 | 2.111 | 1.112 | 734 | 2.521 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 43.782 | 0 | 11 | 0 | 8 | 8 | 34 | 40 |
| Cash | - | - | 139 | 711 | 690 | 251 | 2.103 | 1.104 | 701 | 2.481 |
| Shareholders Funds | - | - | -1.864 | -8.785 | -17.878 | -17.335 | -14.969 | -14.072 | -12.794 | -10.866 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 45.297 | 9.817 | 18.579 | 17.587 | 17.126 | 15.183 | 13.553 | 13.463 |
| Income in Advance | - | - | 43.782 | 37.018 | 31.115 | 25.438 | 19.899 | 14.970 | 9.950 | 4.947 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mbs Alfamed Srl